title: [The dynamics of blood lipid composition in patients with ischemic heart disease in the process of multiple laser therapy combined with anaprilin and verapamil administration].
abstract: 40 patients with ischemic heart disease and angina of effort (class II-III) exposed to laser therapy each 6 months for 2 years entered the study. 23 of these patients received anaprilin (group 1), 17--verapamil (group 2) in mean daily doses. In both groups blood cholesterol decreased for 12 months after the drug treatment. After that in group 2 cholesterol levels persisted at lower values, in group 1 cholesterol levels returned to initial values in 24 months. The positive effect of verapamil on lipid structure of red cell membrane evidences for biological synergism of this drug with laser radiation. Combination of anaprilin with laser radiation produced a hypocholesterolemic effect for 12 months, but after that cholesterol was on the increase.
authors.affiliation: NII klinicheskoĭ i profilakticheskoĭ kardiologii CO RAMN, Tiumen'
authors.forename: A P
authors.initials: AP
authors.lastname: Vasil'ev
authors.forename: N N
authors.initials: NN
authors.lastname: Strel'tsova
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Senatorov
authors.forename: N A
authors.initials: NA
authors.lastname: Mironova
mesh_terms: D002784:Cholesterol / Q000097:blood*; D003131:Combined Modality Therapy; D006801:Humans; D007259:Infrared Rays / Q000627:therapeutic use*; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood* / Q000628:therapy*; D011433:Propranolol / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D014280:Triglycerides; D014665:Vasodilator Agents; D002784:Cholesterol; D011433:Propranolol; D014700:Verapamil